Gene ID Gene Name Transcript ID Transcript Name Transcript Type Disease Association HGNC ID Location Strand HSA-LNCG005753 CDKN2B-AS1 HSA-LNCT005753.1 CDKN2B-AS1-004 antisense Human prostate Cancer, atherosclerosis, susceptible gene for diabetes type 2, glioma, basal cell carcinoma N/A 9:21994790-22121094 + HSA-LNCG005753 CDKN2B-AS1 HSA-LNCT005753.2 CDKN2B-AS1-003 processed transcript Human prostate Cancer, atherosclerosis, susceptible gene for diabetes type 2, glioma, basal cell carcinoma N/A 9:22046750-22118701 + HSA-LNCG005753 CDKN2B-AS1 HSA-LNCT005753.3 CDKN2B-AS1-002 processed transcript Human prostate Cancer, atherosclerosis, susceptible gene for diabetes type 2, glioma, basal cell carcinoma N/A 9:22049184-22077890 + HSA-LNCG005753 CDKN2B-AS1 HSA-LNCT005753.4 CDKN2B-AS1-001 processed transcript Human prostate Cancer, atherosclerosis, susceptible gene for diabetes type 2, glioma, basal cell carcinoma N/A 9:22113677-22121096 + HSA-LNCG004395 GAS5 HSA-LNCT004395.1 GAS5-008 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833038-173837127 - HSA-LNCG004395 GAS5 HSA-LNCT004395.2 GAS5-027 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173838020 - HSA-LNCG004395 GAS5 HSA-LNCT004395.3 GAS5-004 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173837127 - HSA-LNCG004395 GAS5 HSA-LNCT004395.4 GAS5-002 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173837127 - HSA-LNCG004395 GAS5 HSA-LNCT004395.5 GAS5-022 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173837125 - HSA-LNCG004395 GAS5 HSA-LNCT004395.6 GAS5-001 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173837125 - HSA-LNCG004395 GAS5 HSA-LNCT004395.7 GAS5-013 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173837121 - HSA-LNCG004395 GAS5 HSA-LNCT004395.8 GAS5-029 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173836181 - HSA-LNCG004395 GAS5 HSA-LNCT004395.9 GAS5-017 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173836181 - HSA-LNCG004395 GAS5 HSA-LNCT004395.10 GAS5-003 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173836181 - HSA-LNCG004395 GAS5 HSA-LNCT004395.11 GAS5-028 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833039-173835344 - HSA-LNCG004395 GAS5 HSA-LNCT004395.12 GAS5-019 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833040-173836181 - HSA-LNCG004395 GAS5 HSA-LNCT004395.13 GAS5-026 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833040-173834009 - HSA-LNCG004395 GAS5 HSA-LNCT004395.14 GAS5-023 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833042-173834044 - HSA-LNCG004395 GAS5 HSA-LNCT004395.15 GAS5-014 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833049-173836953 - HSA-LNCG004395 GAS5 HSA-LNCT004395.16 GAS5-025 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833092-173834043 - HSA-LNCG004395 GAS5 HSA-LNCT004395.17 GAS5-024 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833118-173834039 - HSA-LNCG004395 GAS5 HSA-LNCT004395.18 GAS5-010 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833154-173837127 - HSA-LNCG004395 GAS5 HSA-LNCT004395.19 GAS5-021 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833622-173836168 - HSA-LNCG004395 GAS5 HSA-LNCT004395.20 GAS5-018 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173833769-173836181 - HSA-LNCG004395 GAS5 HSA-LNCT004395.21 GAS5-009 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834093-173837127 - HSA-LNCG004395 GAS5 HSA-LNCT004395.22 GAS5-012 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834306-173837126 - HSA-LNCG004395 GAS5 HSA-LNCT004395.23 GAS5-007 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834387-173837129 - HSA-LNCG004395 GAS5 HSA-LNCT004395.24 GAS5-011 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834491-173837127 - HSA-LNCG004395 GAS5 HSA-LNCT004395.25 GAS5-015 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834662-173836867 - HSA-LNCG004395 GAS5 HSA-LNCT004395.26 GAS5-006 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834956-173837125 - HSA-LNCG004395 GAS5 HSA-LNCT004395.27 GAS5-016 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173834997-173836827 - HSA-LNCG004395 GAS5 HSA-LNCT004395.28 GAS5-020 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173835005-173836178 - HSA-LNCG004395 GAS5 HSA-LNCT004395.29 GAS5-005 non_coding Melanoma, breast and prostate cancer HGNC:16355 1:173835354-173837125 - HSA-LNCG002710 XIST HSA-LNCT002710.1 XIST-005 processed transcript ovarian cancers HGNC:12810 X:73040486-73046290 - HSA-LNCG002710 XIST HSA-LNCT002710.2 XIST-003 processed transcript ovarian cancers HGNC:12810 X:73040488-73046641 - HSA-LNCG002710 XIST HSA-LNCT002710.3 XIST-006 processed transcript ovarian cancers HGNC:12810 X:73040491-73046136 - HSA-LNCG002710 XIST HSA-LNCT002710.4 XIST-002 processed transcript ovarian cancers HGNC:12810 X:73040491-73046179 - HSA-LNCG002710 XIST HSA-LNCT002710.5 XIST-001 processed transcript ovarian cancers HGNC:12810 X:73040491-73072588 - HSA-LNCG002710 XIST HSA-LNCT002710.6 XIST-201 processed transcript ovarian cancers HGNC:12810 X:73046289-73047729 - HSA-LNCG002710 XIST HSA-LNCT002710.7 XIST-007 processed transcript ovarian cancers HGNC:12810 X:73047544-73049302 - HSA-LNCG002710 XIST HSA-LNCT002710.8 XIST-004 processed transcript ovarian cancers HGNC:12810 X:73047636-73051045 - HSA-LNCG006295 NEAT1 HSA-LNCT006295.1 NEAT1-002 lincRNA Huntington's disease HGNC:30815 11:65190245-65192232 + HSA-LNCG006295 NEAT1 HSA-LNCT006295.2 NEAT1-001 lincRNA Huntington's disease HGNC:30815 11:65190269-65213011 + HSA-LNCG007826 TUG1 HSA-LNCT007826.1 TUG1-003 lincRNA Huntington's disease HGNC:26066 22:31366663-31372049 + HSA-LNCG007826 TUG1 HSA-LNCT007826.2 TUG1-001 lincRNA Huntington's disease HGNC:26066 22:31367034-31369414 + HSA-LNCG007826 TUG1 HSA-LNCT007826.3 TUG1-006 lincRNA Huntington's disease HGNC:26066 22:31367052-31374831 + HSA-LNCG007826 TUG1 HSA-LNCT007826.4 TUG1-002 lincRNA Huntington's disease HGNC:26066 22:31367353-31372049 + HSA-LNCG007826 TUG1 HSA-LNCT007826.5 TUG1-004 lincRNA Huntington's disease HGNC:26066 22:31367425-31369342 + HSA-LNCG007826 TUG1 HSA-LNCT007826.6 TUG1-005 lincRNA Huntington's disease HGNC:26066 22:31367466-31369095 + HSA-LNCG007826 TUG1 HSA-LNCT007826.7 TUG1-007 lincRNA Huntington's disease HGNC:26066 22:31369398-31371465 + HSA-LNCG002854 ATXN8OS HSA-LNCT002854.1 ATXN8OS-002 antisense Spinocerebellar ataxia HGNC:10561 13:70681345-70704974 + HSA-LNCG002854 ATXN8OS HSA-LNCT002854.2 ATXN8OS-001 antisense Spinocerebellar ataxia HGNC:10561 13:70682044-70705678 + HSA-LNCG009492 NKX2-2-AS1 HSA-LNCT009492.1 NKX2-2-AS1-001 antisense HGNC:37154 20:21492085-21492947 + HSA-LNCG004692 GNAS-AS1 HSA-LNCT004692.1 GNAS-AS1-001 antisense pseudohypoparathyroidism type Ib (20444925) HGNC:24872 20:57393974-57425958 - HSA-LNCG004692 GNAS-AS1 HSA-LNCT004692.2 GNAS-AS1-002 antisense pseudohypoparathyroidism type Ib (20444925) HGNC:24872 20:57414837-57415899 - HSA-LNCG009610 KCNQ1OT1 HSA-LNCT009610.1 KCNQ1OT1-001 antisense Beckwith-Wiedemann syndrome, cancers N/A 11:2696556-2721224 - HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.1 LSAMP-AS3-004 antisense osteosarcoma HGNC:27701 3:116428626-116442428 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.2 LSAMP-AS3-001 antisense osteosarcoma HGNC:27701 3:116428626-116435878 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.3 LSAMP-AS3-005 antisense osteosarcoma HGNC:27701 3:116428671-116431318 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.4 LSAMP-AS3-003 antisense osteosarcoma HGNC:27701 3:116428680-116435282 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.5 LSAMP-AS3-002 antisense osteosarcoma HGNC:27701 3:116428816-116435278 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.6 LSAMP-AS3-006 antisense osteosarcoma HGNC:27701 3:116428816-116435278 + HSA-LNCG001345 MIAT HSA-LNCT001345.1 MIAT-005 processed transcript Myocardial infarction (17066261) N/A 22:27042392-27061841 + HSA-LNCG001345 MIAT HSA-LNCT001345.2 MIAT-006 processed transcript Myocardial infarction (17066261) N/A 22:27042604-27061603 + HSA-LNCG001345 MIAT HSA-LNCT001345.3 MIAT-007 processed transcript Myocardial infarction (17066261) N/A 22:27043175-27061701 + HSA-LNCG001345 MIAT HSA-LNCT001345.4 MIAT-008 processed transcript Myocardial infarction (17066261) N/A 22:27043188-27061873 + HSA-LNCG001345 MIAT HSA-LNCT001345.5 MIAT-009 processed transcript Myocardial infarction (17066261) N/A 22:27043192-27061773 + HSA-LNCG001345 MIAT HSA-LNCT001345.6 MIAT-010 processed transcript Myocardial infarction (17066261) N/A 22:27053190-27061836 + HSA-LNCG001345 MIAT HSA-LNCT001345.7 MIAT-011 processed transcript Myocardial infarction (17066261) N/A 22:27053220-27062159 + HSA-LNCG001345 MIAT HSA-LNCT001345.8 MIAT-012 processed transcript Myocardial infarction (17066261) N/A 22:27053220-27061733 + HSA-LNCG001345 MIAT HSA-LNCT001345.9 MIAT-013 processed transcript Myocardial infarction (17066261) N/A 22:27053231-27061779 + HSA-LNCG001345 MIAT HSA-LNCT001345.10 MIAT-014 processed transcript Myocardial infarction (17066261) N/A 22:27053244-27061913 + HSA-LNCG001345 MIAT HSA-LNCT001345.11 MIAT-015 processed transcript Myocardial infarction (17066261) N/A 22:27053244-27061882 + HSA-LNCG001345 MIAT HSA-LNCT001345.12 MIAT-016 processed transcript Myocardial infarction (17066261) N/A 22:27053248-27061987 + HSA-LNCG001345 MIAT HSA-LNCT001345.13 MIAT-001 processed transcript Myocardial infarction (17066261) N/A 22:27053336-27072438 + HSA-LNCG001345 MIAT HSA-LNCT001345.14 MIAT-018 processed transcript Myocardial infarction (17066261) N/A 22:27053422-27062144 + HSA-LNCG001345 MIAT HSA-LNCT001345.15 MIAT-002 processed transcript Myocardial infarction (17066261) N/A 22:27053432-27072438 + HSA-LNCG001345 MIAT HSA-LNCT001345.16 MIAT-004 processed transcript Myocardial infarction (17066261) N/A 22:27053484-27072438 + HSA-LNCG001345 MIAT HSA-LNCT001345.17 MIAT-003 processed transcript Myocardial infarction (17066261) N/A 22:27053484-27072438 + HSA-LNCG001345 MIAT HSA-LNCT001345.18 MIAT-020 processed transcript Myocardial infarction (17066261) N/A 22:27053552-27061816 + HSA-LNCG001345 MIAT HSA-LNCT001345.19 MIAT-021 processed transcript Myocardial infarction (17066261) N/A 22:27053553-27062002 + HSA-LNCG001345 MIAT HSA-LNCT001345.20 MIAT-022 processed transcript Myocardial infarction (17066261) N/A 22:27053575-27061643 + HSA-LNCG001345 MIAT HSA-LNCT001345.21 MIAT-023 processed transcript Myocardial infarction (17066261) N/A 22:27053578-27061757 + HSA-LNCG001739 DANCR HSA-LNCT001739.1 DANCR-001 processed transcript HGNC:28964 4:53578597-53580304 + HSA-LNCG001739 DANCR HSA-LNCT001739.2 DANCR-003 retained intron HGNC:28964 4:53578665-53579296 + HSA-LNCG001739 DANCR HSA-LNCT001739.3 DANCR-002 retained intron HGNC:28964 4:53578948-53580304 + HSA-LNCG001739 DANCR HSA-LNCT001739.4 DANCR-004 processed transcript HGNC:28964 4:53578991-53586518 + HSA-LNCG000072 MIR31HG HSA-LNCT000072.1 MIR31HG-001 processed transcript breast cancer HGNC:37187 9:21455641-21559668 - HSA-LNCG005104 CBR3-AS1 HSA-LNCT005104.1 CBR3-AS1-001 processed transcript prostate cancer HGNC:43664 21:37504065-37528605 - HSA-LNCG005104 CBR3-AS1 HSA-LNCT005104.2 CBR3-AS1-002 processed transcript prostate cancer HGNC:43664 21:37504084-37528593 - HSA-LNCG005104 CBR3-AS1 HSA-LNCT005104.3 CBR3-AS1-003 processed transcript prostate cancer HGNC:43664 21:37513694-37528604 - HSA-LNCG005104 CBR3-AS1 HSA-LNCT005104.4 CBR3-AS1-004 retained intron prostate cancer HGNC:43664 21:37513705-37523008 - HSA-LNCG000026 H19 HSA-LNCT000026.1 H19-015 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016406-2017421 - HSA-LNCG000026 H19 HSA-LNCT000026.2 H19-004 retained intron Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016406-2018447 - HSA-LNCG000026 H19 HSA-LNCT000026.3 H19-003 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016406-2018690 - HSA-LNCG000026 H19 HSA-LNCT000026.4 H19-002 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016406-2019044 - HSA-LNCG000026 H19 HSA-LNCT000026.5 H19-001 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016406-2019105 - HSA-LNCG000026 H19 HSA-LNCT000026.6 H19-201 processed transcript Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016408-2019072 - HSA-LNCG000026 H19 HSA-LNCT000026.7 H19-009 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016440-2019027 - HSA-LNCG000026 H19 HSA-LNCT000026.8 H19-006 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016446-2019057 - HSA-LNCG000026 H19 HSA-LNCT000026.9 H19-005 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016464-2018255 - HSA-LNCG000026 H19 HSA-LNCT000026.10 H19-008 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016467-2019027 - HSA-LNCG000026 H19 HSA-LNCT000026.11 H19-007 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016467-2019045 - HSA-LNCG000026 H19 HSA-LNCT000026.12 H19-013 retained intron Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016669-2017801 - HSA-LNCG000026 H19 HSA-LNCT000026.13 H19-012 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016913-2022700 - HSA-LNCG000026 H19 HSA-LNCT000026.14 H19-014 lincRNA Lung, liver, breast, colorectal, prostate, ovary, cervix, gastric, esophageal and bladder cancer. HGNC:4713 11:2016918-2017697 - HSA-LNCG002314 HOTAIR HSA-LNCT002314.1 HOTAIR-001 antisense Breast cancer, hepatocellular carcinoma HGNC:33510 12:54356092-54368740 - HSA-LNCG002314 HOTAIR HSA-LNCT002314.2 HOTAIR-002 antisense Breast cancer, hepatocellular carcinoma HGNC:33510 12:54357533-54368731 - HSA-LNCG002314 HOTAIR HSA-LNCT002314.3 HOTAIR-005 antisense Breast cancer, hepatocellular carcinoma HGNC:33510 12:54357586-54360414 - HSA-LNCG002314 HOTAIR HSA-LNCT002314.4 HOTAIR-004 antisense Breast cancer, hepatocellular carcinoma HGNC:33510 12:54357685-54361139 - HSA-LNCG002314 HOTAIR HSA-LNCT002314.5 HOTAIR-003 antisense Breast cancer, hepatocellular carcinoma HGNC:33510 12:54357869-54362698 - HSA-LNCG007673 MALAT1 HSA-LNCT007673.1 MALAT1-001 non_coding Cancers of Breast, cervix, colon, lung, uterus, pancreas,liver,osteosarcoma, neuroblastoma. N/A 11:65265233-65273940 + HSA-LNCG007673 MALAT1 HSA-LNCT007673.2 MALAT1-201 processed transcript Cancers of Breast, cervix, colon, lung, uterus, pancreas,liver,osteosarcoma, neuroblastoma. N/A 11:65266516-65271100 + HSA-LNCG007673 MALAT1 HSA-LNCT007673.3 MALAT1-002 processed transcript Cancers of Breast, cervix, colon, lung, uterus, pancreas,liver,osteosarcoma, neuroblastoma. N/A 11:65269807-65271080 + HSA-LNCG007522 HULC HSA-LNCT007522.1 HULC-001 lincRNA Hepatocellular carcinomas and hepatic colorectal metastasis HGNC:34232 6:8652370-8654079 + HSA-LNCG001905 PCGEM1 HSA-LNCT001905.1 PCGEM1-001 processed transcript Prostate cancer HGNC:30145 2:193614571-193641625 + HSA-LNCG004443 MIR155HG HSA-LNCT004443.1 MIR155HG-001 non_coding B cell lymphoma HGNC:35460 21:26934221-26947480 + HSA-LNCG001398 PCA3 HSA-LNCT001398.1 PCA3-001 antisense Prostate cancer HGNC:8637 9:79379352-79402485 + HSA-LNCG000445 MEG3 HSA-LNCT000445.1 MEG3-001 lincRNA Brain tumor HGNC:14575 14:101292445-101327360 + HSA-LNCG000445 MEG3 HSA-LNCT000445.2 MEG3-006 lincRNA Brain tumor HGNC:14575 14:101292463-101327368 + HSA-LNCG000445 MEG3 HSA-LNCT000445.3 MEG3-025 lincRNA Brain tumor HGNC:14575 14:101292463-101327345 + HSA-LNCG000445 MEG3 HSA-LNCT000445.4 MEG3-013 lincRNA Brain tumor HGNC:14575 14:101292463-101327326 + HSA-LNCG000445 MEG3 HSA-LNCT000445.5 MEG3-002 lincRNA Brain tumor HGNC:14575 14:101292463-101327307 + HSA-LNCG000445 MEG3 HSA-LNCT000445.6 MEG3-007 lincRNA Brain tumor HGNC:14575 14:101292464-101327331 + HSA-LNCG000445 MEG3 HSA-LNCT000445.7 MEG3-026 lincRNA Brain tumor HGNC:14575 14:101292469-101327363 + HSA-LNCG000445 MEG3 HSA-LNCT000445.8 MEG3-016 lincRNA Brain tumor HGNC:14575 14:101292471-101327345 + HSA-LNCG000445 MEG3 HSA-LNCT000445.9 MEG3-012 lincRNA Brain tumor HGNC:14575 14:101292485-101327314 + HSA-LNCG000445 MEG3 HSA-LNCT000445.10 MEG3-005 lincRNA Brain tumor HGNC:14575 14:101296942-101327358 + HSA-LNCG000445 MEG3 HSA-LNCT000445.11 MEG3-027 lincRNA Brain tumor HGNC:14575 14:101297818-101327363 + HSA-LNCG000445 MEG3 HSA-LNCT000445.12 MEG3-011 lincRNA Brain tumor HGNC:14575 14:101299306-101327358 + HSA-LNCG000445 MEG3 HSA-LNCT000445.13 MEG3-018 lincRNA Brain tumor HGNC:14575 14:101300101-101327358 + HSA-LNCG000445 MEG3 HSA-LNCT000445.14 MEG3-021 lincRNA Brain tumor HGNC:14575 14:101301863-101327153 + HSA-LNCG000445 MEG3 HSA-LNCT000445.15 MEG3-019 lincRNA Brain tumor HGNC:14575 14:101302057-101327324 + HSA-LNCG000445 MEG3 HSA-LNCT000445.16 MEG3-022 lincRNA Brain tumor HGNC:14575 14:101302143-101327096 + HSA-LNCG000445 MEG3 HSA-LNCT000445.17 MEG3-029 lincRNA Brain tumor HGNC:14575 14:101245747-101295522 + HSA-LNCG000445 MEG3 HSA-LNCT000445.18 MEG3-003 lincRNA Brain tumor HGNC:14575 14:101292455-101311828 + HSA-LNCG000445 MEG3 HSA-LNCT000445.19 MEG3-015 lincRNA Brain tumor HGNC:14575 14:101292456-101313634 + HSA-LNCG000445 MEG3 HSA-LNCT000445.20 MEG3-009 lincRNA Brain tumor HGNC:14575 14:101292463-101313643 + HSA-LNCG000445 MEG3 HSA-LNCT000445.21 MEG3-010 lincRNA Brain tumor HGNC:14575 14:101292470-101299665 + HSA-LNCG000445 MEG3 HSA-LNCT000445.22 MEG3-004 lincRNA Brain tumor HGNC:14575 14:101293748-101295643 + HSA-LNCG000445 MEG3 HSA-LNCT000445.23 MEG3-014 lincRNA Brain tumor HGNC:14575 14:101295638-101302637 + HSA-LNCG000445 MEG3 HSA-LNCT000445.24 MEG3-023 lincRNA Brain tumor HGNC:14575 14:101295948-101311855 + HSA-LNCG000445 MEG3 HSA-LNCT000445.25 MEG3-020 lincRNA Brain tumor HGNC:14575 14:101298401-101302560 + HSA-LNCG000445 MEG3 HSA-LNCT000445.26 MEG3-008 lincRNA Brain tumor HGNC:14575 14:101299615-101313638 + HSA-LNCG000445 MEG3 HSA-LNCT000445.27 MEG3-028 lincRNA Brain tumor HGNC:14575 14:101323582-101327355 + HSA-LNCG000445 MEG3 HSA-LNCT000445.28 MEG3-024 lincRNA Brain tumor HGNC:14575 14:101323961-101327358 + HSA-LNCG005535 PRINS HSA-LNCT005535.1 PRINS-001 processed transcript Psoriasis HGNC:34235 10:24536051-24544975 + HSA-LNCG005100 BCYRN1 HSA-LNCT005100.1 BCYRN1-001 lincRNA Breast cancer, Aging, Alzheimer's disease HGNC:1022 2:47558199-47571656 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.1 LSAMP-AS3-004 antisense Osteosarcoma HGNC:27701 3:116428626-116442428 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.2 LSAMP-AS3-001 antisense Osteosarcoma HGNC:27701 3:116428626-116435878 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.3 LSAMP-AS3-005 antisense Osteosarcoma HGNC:27701 3:116428671-116431318 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.4 LSAMP-AS3-003 antisense Osteosarcoma HGNC:27701 3:116428680-116435282 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.5 LSAMP-AS3-002 antisense Osteosarcoma HGNC:27701 3:116428816-116435278 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.6 LSAMP-AS3-006 antisense Osteosarcoma HGNC:27701 3:116428816-116435278 + HSA-LNCG000433 UCA1 HSA-LNCT000433.1 UCA1-001 non_coding Bladder Carcinoma, Pancreaticobiliary malfunction HGNC:37126 19:15939757-15947130 + HSA-LNCG009606 RN7SL1 HSA-LNCT009606.1 RN7SL1-001 antisense HGNC:10038 14:50053297-50053596 + HSA-LNCG001248 CYP4A22-AS1 HSA-LNCT001248.1 CYP4A22-AS1-001 lincRNA HGNC:43715 1:47562325-47644943 - HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.1 OIP5-AS1-002 lincRNA HGNC:43563 15:41576188-41590979 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.2 OIP5-AS1-004 retained intron HGNC:43563 15:41576188-41578624 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.3 OIP5-AS1-001 lincRNA HGNC:43563 15:41576203-41598732 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.4 OIP5-AS1-006 non_coding HGNC:43563 15:41576204-41589488 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.5 OIP5-AS1-010 lincRNA HGNC:43563 15:41576206-41590267 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.6 OIP5-AS1-005 non_coding HGNC:43563 15:41576206-41580469 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.7 OIP5-AS1-008 retained intron HGNC:43563 15:41576208-41577887 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.8 OIP5-AS1-009 non_coding HGNC:43563 15:41576219-41579672 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.9 OIP5-AS1-007 non_coding HGNC:43563 15:41576229-41580723 + HSA-LNCG006429 OIP5-AS1 HSA-LNCT006429.10 OIP5-AS1-003 non_coding HGNC:43563 15:41576230-41601901 + HSA-LNCG009613 DIO3OS HSA-LNCT009613.1 DIO3OS-001 lincRNA HGNC:20348 14:102018558-102026740 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.2 DIO3OS-013 lincRNA HGNC:20348 14:102018560-102022013 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.3 DIO3OS-012 lincRNA HGNC:20348 14:102018560-102022013 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.4 DIO3OS-008 lincRNA HGNC:20348 14:102023641-102026768 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.5 DIO3OS-007 lincRNA HGNC:20348 14:102023641-102026759 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.6 DIO3OS-006 lincRNA HGNC:20348 14:102023641-102026748 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.7 DIO3OS-009 lincRNA HGNC:20348 14:102023641-102026712 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.8 DIO3OS-016 lincRNA HGNC:20348 14:102023641-102025113 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.9 DIO3OS-003 lincRNA HGNC:20348 14:102023645-102026740 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.10 DIO3OS-002 lincRNA HGNC:20348 14:102023645-102026740 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.11 DIO3OS-015 lincRNA HGNC:20348 14:102024890-102026643 - HSA-LNCG009613 DIO3OS HSA-LNCT009613.12 DIO3OS-014 lincRNA HGNC:20348 14:102025925-102026729 - HSA-LNCG004804 EGOT HSA-LNCT004804.1 EGOT-001 non_coding HGNC:37129 3:4790876-4793274 - HSA-LNCG002718 EMX2OS HSA-LNCT002718.1 EMX2OS-002 antisense Endometrial tumors HGNC:18511 10:119232726-119301830 - HSA-LNCG002718 EMX2OS HSA-LNCT002718.2 EMX2OS-006 antisense Endometrial tumors HGNC:18511 10:119249162-119304579 - HSA-LNCG002718 EMX2OS HSA-LNCT002718.3 EMX2OS-001 antisense Endometrial tumors HGNC:18511 10:119249996-119301845 - HSA-LNCG002718 EMX2OS HSA-LNCT002718.4 EMX2OS-004 antisense Endometrial tumors HGNC:18511 10:119232726-119245709 - HSA-LNCG002718 EMX2OS HSA-LNCT002718.5 EMX2OS-005 antisense Endometrial tumors HGNC:18511 10:119232726-119236135 - HSA-LNCG002718 EMX2OS HSA-LNCT002718.6 EMX2OS-003 antisense Endometrial tumors HGNC:18511 10:119250160-119254199 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.1 SNHG1-025 processed transcript HGNC:32688 11:62619460-62623353 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.2 SNHG1-002 processed transcript HGNC:32688 11:62619460-62623339 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.3 SNHG1-001 processed transcript HGNC:32688 11:62619460-62623218 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.4 SNHG1-006 processed transcript HGNC:32688 11:62619460-62622708 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.5 SNHG1-003 processed transcript HGNC:32688 11:62619461-62623357 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.6 SNHG1-004 processed transcript HGNC:32688 11:62619463-62622932 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.7 SNHG1-005 processed transcript HGNC:32688 11:62619492-62622708 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.8 SNHG1-022 processed transcript HGNC:32688 11:62619520-62621168 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.9 SNHG1-014 processed transcript HGNC:32688 11:62619724-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.10 SNHG1-007 processed transcript HGNC:32688 11:62619730-62623386 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.11 SNHG1-020 processed transcript HGNC:32688 11:62619762-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.12 SNHG1-021 processed transcript HGNC:32688 11:62619769-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.13 SNHG1-019 processed transcript HGNC:32688 11:62620081-62622939 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.14 SNHG1-015 processed transcript HGNC:32688 11:62620221-62622932 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.15 SNHG1-018 processed transcript HGNC:32688 11:62620304-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.16 SNHG1-024 processed transcript HGNC:32688 11:62620544-62621814 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.17 SNHG1-017 processed transcript HGNC:32688 11:62620545-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.18 SNHG1-016 processed transcript HGNC:32688 11:62620826-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.19 SNHG1-013 processed transcript HGNC:32688 11:62621019-62622951 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.20 SNHG1-023 processed transcript HGNC:32688 11:62621045-62622646 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.21 SNHG1-008 processed transcript HGNC:32688 11:62621552-62623284 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.22 SNHG1-011 processed transcript HGNC:32688 11:62621840-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.23 SNHG1-012 processed transcript HGNC:32688 11:62621914-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.24 SNHG1-010 processed transcript HGNC:32688 11:62622152-62622960 - HSA-LNCG008828 SNHG1 HSA-LNCT008828.25 SNHG1-009 processed transcript HGNC:32688 11:62622154-62623230 - HSA-LNCG005953 SNHG3 HSA-LNCT005953.1 SNHG3-001 processed transcript retinitis pigmentosa, Genetic Diseases, X-Linked HGNC:10118 1:28832492-28837404 + HSA-LNCG005953 SNHG3 HSA-LNCT005953.2 SNHG3-002 processed transcript retinitis pigmentosa, Genetic Diseases, X-Linked HGNC:10118 1:28832863-28836145 + HSA-LNCG005953 SNHG3 HSA-LNCT005953.3 SNHG3-003 processed transcript retinitis pigmentosa, Genetic Diseases, X-Linked HGNC:10118 1:28832555-28834782 + HSA-LNCG006325 SNHG6 HSA-LNCT006325.1 SNHG6-005 non_coding HGNC:32965 8:67833919-67837776 - HSA-LNCG006325 SNHG6 HSA-LNCT006325.2 SNHG6-003 non_coding HGNC:32965 8:67834053-67837831 - HSA-LNCG006325 SNHG6 HSA-LNCT006325.3 SNHG6-001 non_coding HGNC:32965 8:67834165-67837777 - HSA-LNCG006325 SNHG6 HSA-LNCT006325.4 SNHG6-006 non_coding HGNC:32965 8:67834222-67837776 - HSA-LNCG006325 SNHG6 HSA-LNCT006325.5 SNHG6-002 non_coding HGNC:32965 8:67834230-67837776 - HSA-LNCG006325 SNHG6 HSA-LNCT006325.6 SNHG6-004 non_coding HGNC:32965 8:67834253-67838633 - HSA-LNCG006325 SNHG6 HSA-LNCT006325.7 SNHG6-007 processed transcript HGNC:32965 8:67834506-67837776 - HSA-LNCG006028 SOX2-OT HSA-LNCT006028.1 SOX2-OT-003 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:180774468-181457813 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.2 SOX2-OT-004 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:180774473-181417572 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.3 SOX2-OT-002 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:180892932-181457445 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.4 SOX2-OT-008 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181281509-181460261 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.5 SOX2-OT-010 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181328122-181457481 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.6 SOX2-OT-009 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181328151-181459018 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.7 SOX2-OT-011 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181328312-181457661 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.8 SOX2-OT-012 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181328317-181508734 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.9 SOX2-OT-013 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181328329-181417668 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.10 SOX2-OT-016 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181328397-181428083 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.11 SOX2-OT-005 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:180721562-180893607 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.12 SOX2-OT-001 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:180892813-181281643 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.13 SOX2-OT-006 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181281244-181348678 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.14 SOX2-OT-007 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181281498-181389529 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.15 SOX2-OT-014 retained intron Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181417281-181457867 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.16 SOX2-OT-015 retained intron Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181417284-181457786 + HSA-LNCG006028 SOX2-OT HSA-LNCT006028.17 SOX2-OT-017 processed transcript Associated with anopthalmia due to mutation in sox2 HGNC:20209 3:181417382-181417888 + HSA-LNCG001533 ST7-AS2 HSA-LNCT001533.1 ST7-AS2-002 antisense HGNC:16044 7:116712481-116785612 - HSA-LNCG001533 ST7-AS2 HSA-LNCT001533.2 ST7-AS2-006 antisense HGNC:16044 7:116752346-116785646 - HSA-LNCG001533 ST7-AS2 HSA-LNCT001533.3 ST7-AS2-004 antisense HGNC:16044 7:116752346-116785614 - HSA-LNCG001533 ST7-AS2 HSA-LNCT001533.4 ST7-AS2-001 antisense HGNC:16044 7:116712126-116730834 - HSA-LNCG001533 ST7-AS2 HSA-LNCT001533.5 ST7-AS2-003 antisense HGNC:16044 7:116712126-116714778 - HSA-LNCG001533 ST7-AS2 HSA-LNCT001533.6 ST7-AS2-005 antisense HGNC:16044 7:116785419-116786534 - HSA-LNCG001416 HAR1A HSA-LNCT001416.1 HAR1A-001 processed transcript schizophrenia, Huntington's disease HGNC:33117 20:61733557-61735738 + HSA-LNCG003168 HAR1B HSA-LNCT003168.1 HAR1B-001 processed transcript Huntington's disease HGNC:33118 20:61727150-61733631 - HSA-LNCG003959 HOTAIRM1 HSA-LNCT003959.1 HOTAIRM1-005 antisense HGNC:37117 7:27135266-27135946 + HSA-LNCG003959 HOTAIRM1 HSA-LNCT003959.2 HOTAIRM1-001 antisense HGNC:37117 7:27135713-27139773 + HSA-LNCG003959 HOTAIRM1 HSA-LNCT003959.3 HOTAIRM1-002 antisense HGNC:37117 7:27135743-27139585 + HSA-LNCG003959 HOTAIRM1 HSA-LNCT003959.4 HOTAIRM1-004 antisense HGNC:37117 7:27135852-27139585 + HSA-LNCG003959 HOTAIRM1 HSA-LNCT003959.5 HOTAIRM1-003 antisense HGNC:37117 7:27138458-27139758 + HSA-LNCG000482 RP11-43F13.3 HSA-LNCT000482.1 RP11-43F13.3-201 antisense Wilms tumor N/A 5:987295-990738 - HSA-LNCG000482 RP11-43F13.3 HSA-LNCT000482.2 RP11-43F13.3-001 antisense Wilms tumor N/A 5:987295-997423 - HSA-LNCG001234 JPX HSA-LNCT001234.1 JPX-001 lincRNA HGNC:37191 X:73164177-73220326 + HSA-LNCG001234 JPX HSA-LNCT001234.2 JPX-002 lincRNA HGNC:37191 X:73164181-73164781 + HSA-LNCG001234 JPX HSA-LNCT001234.3 JPX-003 lincRNA HGNC:37191 X:73164202-73167265 + HSA-LNCG002183 KDM5B-AS1 HSA-LNCT002183.1 KDM5B-AS1-003 antisense HGNC:43714 1:202780082-202781284 + HSA-LNCG002183 KDM5B-AS1 HSA-LNCT002183.2 KDM5B-AS1-002 antisense HGNC:43714 1:202780090-202781041 + HSA-LNCG002183 KDM5B-AS1 HSA-LNCT002183.3 KDM5B-AS1-001 antisense HGNC:43714 1:202780090-202781041 + HSA-LNCG002125 LINC00568 HSA-LNCT002125.1 LINC00568-001 lincRNA HGNC:43713 1:150488233-150490508 + HSA-LNCG000802 LINC00570 HSA-LNCT000802.1 LINC00570-001 lincRNA HGNC:43717 2:11534107-11543203 + HSA-LNCG000802 LINC00570 HSA-LNCT000802.2 LINC00570-003 lincRNA HGNC:43717 2:11539128-11542234 + HSA-LNCG000802 LINC00570 HSA-LNCT000802.3 LINC00570-002 lincRNA HGNC:43717 2:11539180-11542384 + HSA-LNCG000802 LINC00570 HSA-LNCT000802.4 LINC00570-004 lincRNA HGNC:43717 2:11539295-11542387 + HSA-LNCG005115 AL121656.5 HSA-LNCT005115.1 AL121656.5-001 lincRNA N/A 2:33152194-33153472 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.1 LSAMP-AS3-004 antisense Osteosarcoma HGNC:27701 3:116428626-116442428 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.2 LSAMP-AS3-001 antisense Osteosarcoma HGNC:27701 3:116428626-116435878 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.3 LSAMP-AS3-005 antisense Osteosarcoma HGNC:27701 3:116428671-116431318 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.4 LSAMP-AS3-003 antisense Osteosarcoma HGNC:27701 3:116428680-116435282 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.5 LSAMP-AS3-002 antisense Osteosarcoma HGNC:27701 3:116428816-116435278 + HSA-LNCG006065 LSAMP-AS3 HSA-LNCT006065.6 LSAMP-AS3-006 antisense Osteosarcoma HGNC:27701 3:116428816-116435278 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.1 ZNFX1-AS1-007 processed transcript Breast Cancer HGNC:33101 20:47894715-47905797 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.2 ZNFX1-AS1-004 processed transcript Breast Cancer HGNC:33101 20:47894715-47905797 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.3 ZNFX1-AS1-003 processed transcript Breast Cancer HGNC:33101 20:47894715-47905797 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.4 ZNFX1-AS1-001 processed transcript Breast Cancer HGNC:33101 20:47894715-47905797 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.5 ZNFX1-AS1-005 processed transcript Breast Cancer HGNC:33101 20:47894808-47905797 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.6 ZNFX1-AS1-006 processed transcript Breast Cancer HGNC:33101 20:47895179-47905797 + HSA-LNCG000107 ZNFX1-AS1 HSA-LNCT000107.7 ZNFX1-AS1-002 processed transcript Breast Cancer HGNC:33101 20:47895179-47905797 + HSA-LNCG005523 ZEB2-AS1 HSA-LNCT005523.1 ZEB2-AS1-001 antisense HGNC:37149 2:145275982-145278683 + HSA-LNCG005523 ZEB2-AS1 HSA-LNCT005523.2 ZEB2-AS1-002 antisense HGNC:37149 2:145277181-145278466 + HSA-LNCG005523 ZEB2-AS1 HSA-LNCT005523.3 ZEB2-AS1-003 antisense HGNC:37149 2:145277421-145278445 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.1 WT1-AS-002 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32457064-32460253 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.2 WT1-AS-001 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32457125-32462950 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.3 WT1-AS-003 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32457322-32458597 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.4 WT1-AS-006 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32457347-32480315 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.5 WT1-AS-004 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32459169-32459872 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.6 WT1-AS-201 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32459475-32461618 + HSA-LNCG000162 WT1-AS HSA-LNCT000162.7 WT1-AS-005 antisense Wilm's Tumor, uterine sarcoma HGNC:18135 11:32459916-32460678 + HSA-LNCG001833 ST7-AS1 HSA-LNCT001833.1 ST7-AS1-001 antisense HGNC:16000 7:116592500-116594388 -